Inactive Instrument

News Xeris Biopharma Holdings, Inc. Nasdaq

Equities

XERS

US98422L1070

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	Apr. 03	BU
Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference	Apr. 02	BU
Oppenheimer Initiates Coverage on Xeris Biopharma With Outperform Rating, $5 Price Target	Mar. 28	MT
Xeris Biopharma Holdings, Inc.(NasdaqGS:XERS) added to S&P Pharmaceuticals Select Industry Index	Mar. 17	CI
Transcript : Xeris Biopharma Holdings, Inc., Q4 2023 Earnings Call, Mar 06, 2024	Mar. 06
Xeris Biopharma: Q4 Earnings Snapshot	Mar. 06	AQ
Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q4 Revenue $44.4M, vs. Street Est of $43.6M	Mar. 06	MT
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events	Mar. 06	BU
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital	Mar. 06	BU
Xeris Biopharma Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 06	CI
Xeris Biopharma Holdings, Inc. Provides Earnings Guidance for the Year 2024	Mar. 06	CI
Xeris Refinances its $150 Million Senior Secured Term Loan Facility with Hayfin Capital	Mar. 06	CI
North American Morning Briefing : Stock Futures -2-	Mar. 06	DJ
Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024	Feb. 28	BU
Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference	Feb. 05	BU
Xeris Biopharma Holdings Seeks Acquisitions	Jan. 11	CI
Transcript : Xeris Biopharma Holdings, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 12:00 PM	Jan. 11
US Equity Markets Close Higher Wednesday as Investors Await Inflation Data	Jan. 10	MT
Sector Update: Health Care Stocks Gain Late Afternoon	Jan. 10	MT
Xeris Biopharma Shares Rise on Licensing Agreement With Amgen	Jan. 10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Xeris Biopharma Holdings, Inc. Nasdaq

Equities

XERS

US98422L1070

Summary

Filters